Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation - Carr, LL; Mankoff, DA; Goulart, BH (Clin Cancer Res, 2010)
et al.